Efficacy of Topical Phenytoin vs Normal Saline Dressing in Management of Diabetic Ulcers
DOI:
https://doi.org/10.51985/Keywords:
Diabetic foot ulcers, Healing, Normal saline dressings, Outcomes, Phenytoin dressingsAbstract
Objective: To compare the outcomes of topical phenytoin vs normal saline (NS) dressings to treat diabetic foot ulcer (DFU).
Study Design and Setting: Quasi-experimental study conducted in the Department of General Surgery, Pak Emirates Military Hospital, Rawalpindi, Pakistan, from January 2024 to June 2024. The study was carried out under standardized clinical protocols, and all patients were managed in a uniform hospital environment to minimize variability in treatment practices and ensure consistency in outcome assessment.
Methodology: One hundred and ten (110) patients were segregated into two equal groups; (1) Phenytoin dressings group, (2) NS dressings group. Outcomes of these groups were compared. A statistical package for Social Sciences (SPSS) version 23 was utilized to assess the results. Data regarding demographic variables, clinical presentation, and wound characteristics were collected systematically using a structured proforma, and all patients were followed regularly to monitor progress and response to treatment.
Results: One hundred and ten (n=110) patients were equally segregated into two groups. In the Phenytoin group, 50(90.90%) patients had improvement in wound (reduction in Wagner Grade) and in NS group 40(72.72%) patients had wound improvement (p-value 0.01). In the Phenytoin group, 2(3.63%) patients developed local complications and in NS group 7(12.72%) patients had local complications (p-value 0.08). In the Phenytoin group, 46(83.63%) patients had complete healing and in NS group 37(67.27%) patients had complete healing (p-value 0.04). Additionally, patient satisfaction was higher in the Phenytoin group, reflecting better overall acceptance of the treatment modality.
Conclusion: Phenytoin dressings were found to be more effective as compared to NS dressings in promoting healing in DFU, with improved clinical outcomes and higher patient satisfaction.
References
1. Banday MZ, Sameer AS, Nissar S. Pathophysiology of
diabetes: an overview. Avicenna J Med. 2020;10(4):174-188.
https://doi.org/10.4103/ajm.ajm_53_20
2. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K,
Duncan BB, et al. IDF Diabetes Atlas: global, regional and
country-level diabetes prevalence estimates for 2021 and
projections for 2045. Diabetes Res Clin Pract. 2022;183:
109119. https://doi.org/10.1016/ j.diabres.2021. 109119
3. Akhtar S, Ali A, Ahmad S, Khan MI, Shah S, Hassan F. The
prevalence of foot ulcers in diabetic patients in Pakistan: a
systematic review and meta-analysis. Front Public Health.
2022;10:1017201. https://doi.org/10.3389/fpubh.2022.1017201
4. McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW.
Etiology, epidemiology, and disparities in the burden of
diabetic foot ulcers. Diabetes Care. 2023;46(1):209-221.
5. Kim J. The pathophysiology of diabetic foot: a narrative
review. J Yeungnam Med Sci. 2023;40(4):328-334.
https://doi.org/10.12701/jyms.2023.00731
6. Shah P, Inturi R, Anne D, Jadhav D, Viswambharan V,
Khadilkar R, et al. Wagner's classification as a tool for treating
diabetic foot ulcers: our observations at a suburban teaching
hospital. Cureus. 2022;14(1):e21501. https://doi.org/10.7759/
cureus.21501
7. Sadiq K, Shivakumar Y, Burra E, Shahid K, Tamene Y, Mody
S, et al. Topical phenytoin improves wound healing with
analgesic and antibacterial properties and minimal side effects:
a systematic review. Wounds. 2024;36:50–608. Nagaraj J, Subbiah V. The efficacy of local insulin versus
topical phenytoin or normal saline in diabetic foot ulcer
management: a prospective comparative study. Cureus.
2022;14(10):e30461. https://doi.org/10.7759/cureus.30461
9. Barry CP, Hameed MSS, Sathyanarayanan A. Efficacy of
topical phenytoin in the management of diabetic foot ulcers:
a systematic review. Cureus. 2025;17(7):e87517. https://doi.org
/1 0.7759/cureus.87517
10. Pratika A, Dayal A, Patel N. Effectiveness of topical phenytoin
versus normal saline dressing in the management of diabetic
foot ulcers: a non-randomized interventional study. Res J Med
Sci. 2025;19:214-220. https://doi.org/10.36478/ makrjms.2025.
2.214.220
11. Yao Y, Chen L, Qian Y. Age characteristics of patients with
type 2 diabetic foot ulcers and predictive risk factors for lower
limb amputation: a population-based retrospective study. J
Diabetes Res. 2024;2024:2380337. https://doi.org/10.1155/
jdr/2380337
12. Iacopi E, Pieruzzi L, Riitano N, Abbruzzese L, Goretti C,
Piaggesi A. The weakness of the strong sex: differences
between men and women affected by diabetic foot disease.
Int J Low Extrem Wounds. 2023;22(1):19-26. https://doi.org/
10.1177/1534734620984604
13. Asif M, Aslam M, Altaf S, Atif S, Majid A. Prevalence and
sociodemographic factors of overweight and obesity among
Pakistani adults. J Obes Metab Syndr. 2020;29(1):58-66.
https://doi.org/10.7570/jomes19039
14. Shaw J, Hughes CM, Lagan KM, Stevenson MR, Irwin CR,
Bell PM, et al. The effect of topical phenytoin on healing in
diabetic foot ulcers: a randomized controlled trial. Diabet
Med. 2011;28(10):1154-1157. https://doi.org/10.1111/j.1464-
5491.2011.03309.x
15. Ahmed A, Ahmed MI. A comparison of efficacy of topical
use of phenytoin and vaseline gauze dressing with vaseline
gauze dressing alone in healing of diabetic foot ulcers. J
Postgrad Med Inst. 2014;28(3):297-302.
16. Patil V, Patil R, Kariholu PL, Patil LS, Shahapur P. Topical
phenytoin application in grade I and II diabetic foot ulcers:
a prospective study. J Clin Diagn Res. 2013;7(10):2238-2240.
https://doi.org/10.7860/JCDR/2013/5713.3480
17. Bharathi Mohan P, Chapa UK, Chittoria RK, Chavan V,
Aggarwal A, Gupta S, et al. Role of phenytoin in diabetic
foot ulcers. J Cutan Aesthet Surg. 2020;13(3):222-225.
https://doi.org/10.4103/JCAS.JCAS_48_19
18. Adana P, Dayal A, Patel N. Effectiveness of topical phenytoin
versus normal saline dressing in the management of diabetic
foot ulcers: a non-randomized interventional study. Res J Med
Sci. 2025;19:214-220. https://doi.org/10.36478
/makrjms.2025.2.214.220
19. C T, Banu AS, Ganesan S. Evaluating the efficacy of topical
phenytoin in the healing of neuropathic diabetic foot ulcers:
a comparative study. Cureus. 2024;16(6):e63282.
https://doi.org/10.7759/cureus.63282
20. Aalaa M, Vahdani AM, Mohajeri Tehrani M, Mehrdad N,
Zohdirad M, Sadati M, et al. Epidemiological insights into
diabetic foot amputation and its correlates: a provincial study.
Clin Med Insights Endocrinol Diabetes. 2024;17:11795514
241227618. https://doi.org/10.1177/ 11795514241227618
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0